NLNatalie A. Lamb

Natalie A. Lamb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Natalie A. Lamb has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Jonathan E. Bard

    University at Buffalo Genomics and Bioinformatics Core, New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York

    3 shared publications
  • Akinsola Oyelakin

    Department of Oral Biology, School of Dental Medicine, State University of New York at Buffalo , Buffalo , NY , USA

    1 shared publication
  • Ashutosh Prakash Dubey

    Department of Microbiology and Immunology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY 14203

    1 shared publication
  • Brianna L. Tylec

    Department of Microbiology and Immunology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY 14203

    1 shared publication
  • Bruce Robert Troen

    Division of Geriatrics, Department of Internal Medicine, and Landon Center on Aging, University of Kansas Medical Center; Research Service, Veterans Affairs Kansas City Healthcare System , Kansas City, Missouri

    1 shared publication
  • C. Gluck

    Department of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA

    1 shared publication

Latest Publications

  • Open Access

    Secure biosystems design in Saccharomyces cerevisiae establishes effective biocontainment strategies and mechanisms of escape

    by Natalie A. Lamb, Kimberly A. Rosenbach, Thomas J. Musselwhite, Kathleen L. Arnolds, Riley C. Higgins, Gabriella A. Li, Jeffrey G. Linger, Michael T. Guarnieri

    The widespread application of recombinant DNA and synthetic biology approaches for microbial metabolic engineering pursuits has motivated the development of biocontainment strategies, targeting safe and secure deployment of genetically modified microorganisms (GMMs). However, the design rules and mechanistic drivers governing biocontainment efficacy, as well as impacts of biocontainment upon microbial fitness, remain to be comprehensively evaluated, hindering predictive design and application of these strategies. We have developed a platform for high-resolution analysis of a transactivated kill switch in laboratory and industrial strains of Saccharomyces cerevisiae to assess modes of biocontainment escape and establish design rules for development of kill switch systems in diverse microbes. A camphor-regulated, RelE toxin system was systematically deployed to assess the impacts of differential kill switch copy number and ploidy in laboratory vs industrial strains. CRISPR-mediated integration of the biocontainment system at various loci revealed rapid escape events driven, in part, by mutations to both the Cam-transactivator (cam-TA) and RelE toxin. Genetic engineering enabled recapitulation of escape phenotypes, confirming mechanisms of escape and establishing structure-function relationships in the cam-TA system. Interestingly, genomic resequencing of escape mutants also revealed a series of off-target mutations, implicating additional modes of kill switch escape. Multi-copy integration of the kill switch system mitigated these effects by orders of magnitude, without compromising the biosynthetic capacity of the microbes, but proved insufficient to establish sustained biocontainment. The resultant data define a series of key design rules for next-generation biocontainment strategies and add to a growing foundational knowledge base targeting establishment of secure biosystems designs. IMPORTANCE: The development of biocontainment mechanisms is essential for safe deployment of microbes in industrial processes and to minimize escape into the natural environment. To achieve secure biosystems designs, a deeper understanding of the mechanistic drivers governing biocontainment efficacy and associated impacts of biocontainment upon microbial fitness are needed. This study uncovers successful biocontainment strategies for kill switch deployment in addition to mechanistic information conferring kill switch escape. Additionally, differential effects were observed in laboratory vs industrial yeasts, implicating auxotrophies and heterothallism as additional drivers of biocontainment. These learnings can inform iterative designs, with the goal of improving the efficacy of biocontainment while maintaining fitness in engineered microbes.


  • Open Access

    Life stage–specific poly(A) site selection regulated byTrypanosoma bruceiDRBD18

    by Jonathan E. Bard, Brianna L. Tylec, Ashutosh P. Dubey, Natalie A. Lamb, Donald A. Yergeau, Laurie K. Read

    The kinetoplastid parasite,Trypanosoma brucei, undergoes a complex life cycle entailing slender and stumpy bloodstream forms in mammals and procyclic and metacyclic forms (MFs) in tsetse fly hosts. The numerous gene regulatory events that underlieT. bruceidifferentiation between hosts, as well as between active and quiescent stages within each host, take place in the near absence of transcriptional control. Rather, differentiation is controlled by RNA-binding proteins (RBPs) that associate with mRNA 3′ untranslated regions (3′UTRs) to impact RNA stability and translational efficiency. DRBD18 is a multifunctionalT. bruceiRBP, shown to impact mRNA stability, translation, export, and processing. Here, we use single-cell RNAseq to characterize transcriptomic changes in cell populations that arise upon DRBD18 depletion, as well as to visualize transcriptome-wide alterations to 3′UTR length. We show that in procyclic insect stages, DRBD18 represses expression of stumpy bloodstream form and MF transcripts. Additionally, DRBD18 regulates the 3′UTR lengths of over 1,500 transcripts, typically promoting the use of distal polyadenylation sites, and thus the inclusion of 3′UTR regulatory elements. Remarkably, comparison of polyadenylation patterns in DRBD18 knockdowns with polyadenylation patterns in stumpy bloodstream forms shows numerous similarities, revealing a role for poly(A) site selection in developmental gene regulation, and indicating that DRBD18 controls this process for a set of transcripts. RNA immunoprecipitation supports a direct role for DRBD18 in poly(A) site selection. This report highlights the importance of alternative polyadenylation inT. bruceidevelopmental control and identifies a critical RBP in this process.


  • Open Access

    Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid‐derived suppressor cells

    by Lixia Zhang, Kyu Hwan Kwack, Ramkumar Thiyagarajan, Kylie K. Mullaney, Natalie A. Lamb, Jonathan E. Bard, Jiho Sohn, Kenneth L. Seldeen, Yukitomo Arao, Perry J. Blackshear, et al.

    Tristetraprolin (TTP; also known as NUP475, GOS24, or TIS11), encoded by Zfp36 , is an RNA‐binding protein that regulates target gene expression by promoting mRNA decay and preventing translation. Although previous studies have indicated that TTP deficiency is associated with systemic inflammation and a catabolic‐like skeletal phenotype, the mechanistic underpinnings remain unclear. Here, using both TTP‐deficient (TTPKO) and myeloid‐specific TTPKO (cTTPKO) mice, we reveal that global absence or loss of TTP in the myeloid compartment results in a reduced bone microarchitecture, whereas gain‐of‐function TTP knock‐in (TTPKI) mice exhibit no significant loss of bone microarchitecture. Flow cytometry analysis revealed a significant immunosuppressive immune cell phenotype with increased monocytic myeloid‐derived suppressor cells (M‐MDSCs) in TTPKO and cTTPKO mice, whereas no significant changes were observed in TTPKI mice. Single‐cell transcriptomic analyses of bone marrow myeloid progenitor cell populations indicated a dramatic increase in early MDSC marker genes for both cTTPKO and TTPKO bone marrow populations. Consistent with these phenotypic and transcriptomic data, in vitro osteoclastogenesis analysis of bone marrow M‐MDSCs from cTTPKO and TTPKO displayed enhanced osteoclast differentiation and functional capacity. Focused transcriptomic analyses of differentiated M‐MDSCs showed increased osteoclast‐specific transcription factors and cell fusion gene expression. Finally, functional data showed that M‐MDSCs from TTP loss‐of‐function mice were capable of osteoclastogenesis and bone resorption in a context‐dependent manner. Collectively, these findings indicate that TTP plays a central role in regulating osteoclastogenesis through multiple mechanisms, including induction of M‐MDSCs that appear to regulate skeletal phenotype.


  • Complex mutation profiles in mismatch repair and ribonucleotide reductase mutants reveal novel repair substrate specificity of MutS homolog (MSH) complexes

    by Natalie A Lamb, Jonathan E Bard, Raphael Loll-Krippleber, Grant W Brown, Jennifer A Surtees

    Determining mutation signatures is standard for understanding the etiology of human tumors and informing cancer treatment. Multiple determinants of DNA replication fidelity prevent mutagenesis that leads to carcinogenesis, including the regulation of free deoxyribonucleoside triphosphate pools by ribonucleotide reductase and repair of replication errors by the mismatch repair system. We identified genetic interactions between rnr1 alleles that skew and/or elevate deoxyribonucleoside triphosphate levels and mismatch repair gene deletions. These defects indicate that the rnr1 alleles lead to increased mutation loads that are normally acted upon by mismatch repair. We then utilized a targeted deep-sequencing approach to determine mutational profiles associated with mismatch repair pathway defects. By combining rnr1 and msh mutations to alter and/or increase deoxyribonucleoside triphosphate levels and alter the mutational load, we uncovered previously unreported specificities of Msh2–Msh3 and Msh2–Msh6. Msh2–Msh3 is uniquely able to direct the repair of G/C single-base deletions in GC runs, while Msh2–Msh6 specifically directs the repair of substitutions that occur at G/C dinucleotides. We also identified broader sequence contexts that influence variant profiles in different genetic backgrounds. Finally, we observed that the mutation profiles in double mutants were not necessarily an additive relationship of mutation profiles in single mutants. Our results have implications for interpreting mutation signatures from human tumors, particularly when mismatch repair is defective.


  • A Global Vista of the Epigenomic State of the Mouse Submandibular Gland

    by C. Gluck, S. Min, A. Oyelakin, M. Che, E. Horeth, E.A.C. Song, J. Bard, N. Lamb, S. Sinha, R.A. Romano

    The parotid, submandibular, and sublingual glands represent a trio of oral secretory glands whose primary function is to produce saliva, facilitate digestion of food, provide protection against microbes, and maintain oral health. While recent studies have begun to shed light on the global gene expression patterns and profiles of salivary glands, particularly those of mice, relatively little is known about the location and identity of transcriptional control elements. Here we have established the epigenomic landscape of the mouse submandibular salivary gland (SMG) by performing chromatin immunoprecipitation sequencing experiments for 4 key histone marks. Our analysis of the comprehensive SMG data sets and comparisons with those from other adult organs have identified critical enhancers and super-enhancers of the mouse SMG. By further integrating these findings with complementary RNA-sequencing based gene expression data, we have unearthed a number of molecular regulators such as members of the Fox family of transcription factors that are enriched and likely to be functionally relevant for SMG biology. Overall, our studies provide a powerful atlas of cis-regulatory elements that can be leveraged for better understanding the transcriptional control mechanisms of the mouse SMG, discovery of novel genetic switches, and modulating tissue-specific gene expression in a targeted fashion.